Long-term safety of once-daily budesonide in patients with early-onset mild persistent asthma: Results of the Inhaled Steroid Treatment as Regular Therapy in Early Asthma (START) study

Annals of Allergy, Asthma and Immunology

Volumn 94, Issue 1, 2005, Pages 48-54

  Sheffer, Albert L ^a   Silverman, Mike ^b   Woolcock, Ann J ^c   Díaz, Patricia V ^d   Lindberg, Bengt ^e   Lindmark, Bertil ^e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF CHILE   (Chile)

^e ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CORTICOSTEROID;

ADOLESCENT; ADULT; AGED; ALLERGIC REACTION; ALLERGY; ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ARTICLE; ASPERGILLOSIS; ASTHMA; BEHAVIOR DISORDER; BRONCHITIS; CANCER; CATARACT; CHICKENPOX; CHILD; CONGENITAL DISORDER; CONJUNCTIVITIS; CONTROLLED STUDY; DEPRESSION; DERMATITIS; DRUG DOSE REGIMEN; DRUG SAFETY; DRUG TOLERABILITY; ECZEMA; FEMALE; GLAUCOMA; HUMAN; HYPERTENSION; HYPOKALEMIA; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MYCOSIS; OSTEOPOROSIS; PHARYNGITIS; PNEUMONIA; PRIORITY JOURNAL; PRURITUS; RASH; RESPIRATORY TRACT INFECTION; RHINITIS; SINUSITIS; SKIN DISEASE; SPONTANEOUS ABORTION; THRUSH; TUBERCULOSIS; URTICARIA; VAGINA CANCER; VIRUS INFECTION; VISUAL DISORDER;

EID: 12344254807     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61285-9     Document Type: Article

References (36)

1. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis. 1993;147:697-704.
2. National Institutes of Health, National Heart, Lung and Blood Institute. National Asthma Education and Prevention Program Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Heart, Lung, and Blood Institute, National Institutes of Health; 1997. Publication 97-4051.
3. National Institutes of Health, National Heart, Lung and Blood Institute. Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention. Bethesda, MD: National Institutes of Health; 2002. Publication 02-3659.
4. Dooms-Goossens A. Allergy to inhaled corticosteroids: a review. Am J Contact Dermatitis. 1995;6:1-3.
5. Lewis LD, Cochrane GM. Psychosis in a child inhaling budesonide. Lancet. 1983;10:634.
6. Phelan MC. Beclomethasone mania. Br J Psychiatry. 1989;155:871-872.
7. Goldstein ET, Preskorn SH. Mania triggered by a steroid nasal spray in a patient with stable bipolar disorder. Am J Psychiatry. 1989;146:1076-1077.
8. Cluley S, Cochrane G. Psychological disorder in asthma is associated with poor control and poor adherence to inhaled steroids. Respir Med. 2001;95:37-39.
9. National Asthma Education Program Report of the Working Group on Asthma and Pregnancy. Management of Asthma During Pregnancy. Bethesda, MD: National Institutes of Health; 1993. Publication 93-3279A.
10. Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med. 2000;343:1054-1063.
11. Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med. 2000;343:1064-1069.
12. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med. 1991;325:388-392.
13. Haahtela T, Jarvinen M, Kava T, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med. 1994;331:700-705.
14. Selroos O, Pietinalho A, Löfroos A-B, Riska H. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest. 1995;108:1228-1234.
15. Selroos OB, Löfroos AB, Niemistö M, et al. Early introduction with inhaled steroids in asthma results in achievement of treatment goals. Am J Respir Crit Care Med. 1999;159(Suppl): A627.
16. Selroos OB, Niemistö M, Löfroos A. A double blind, randomized, dose-response study with budesonide in asthma patients with short or long duration of symptoms. Am J Respir Crit Care Med. 1999;159(Suppl):A627.
17. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med. 1994;88:373-381.
18. Turpeinen M. Helsinki early intervention childhood asthma (HEICA) study: inhaled budesonide halved the number of asthma exacerbations compared with inhaled disodium cromoglycate during 18 months of treatment. Eur Respir J. 2000;16(Suppl):311s.
19. Pauwels RA, Pedersen S, Busse WW, et al; START Investigators Group. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet. 2003;361:1071-1076.
20. O'Hagan AH, Corbett JR. Contact allergy to budesonide in a breath-actuated inhaler, Contact Dermatitis. 1999;41:53.
21. Shaikh WA. Pulmonary tuberculosis in patients treated with inhaled beclomethasone. Allergy. 1992;47:327-330.
22. Dey A. Corticosteroid inhalers and pulmonary tuberculosis. Natl Med J India. 1993;6:23-24.
23. Bahceciler NN, Nuhoglu Y, Nursoy MA, Kodalli N, Barlan IB, Basaran MM. Inhaled corticosteroid therapy is safe in tuberculin-positive asthmatic children. Pediatr Infect Dis J. 2000;19:215-218.
24. Dowell SF, Bresee JS, Severe varicella associated with steroid use. Pediatrics. 1993;92:223-228.
25. Patel H, Macarthur C, Johnson D. Recent corticosteroid use and the risk of complicated varicella in otherwise immunocompetent children. Arch Pediatr Adolesc Med. 1996;150:409-414.
26. Nursoy M, Bakur M, Barlan I, Basaran M. The course of chickenpox in asthmatic children receiving inhaled budesonide. Pediatr Infect Dis J. 1997;16:74-75.
27. Cumming RG, Mitchell P, Leeder SR. Use of inhaled steroids and the risk of cataracts. N Engl J Med. 1997;337:8-14.
28. Garbe E, LeLorier J, Bovin JF, Suissa S. Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids. Lancet. 1997;350:979-982.
29. Jick SS, Vasilakis Scaramozza C, Maier WC. The risk of cataract among users of inhaled steroids. Epidemiology. 2001;12:229-234.
30. Duh MS, Walker AM, Lindmark B, Laties AM. Intraocular pressure and budesonide inhalation therapy: lack of association in a mixed asthmatic population treated with therapeutic doses for up to 20 weeks. Ann Allergy Asthma Immunol. 1999;82:76.
31. Agertoft L, Larsen FE, Pedersen S. Posterior subcapsular cataracts, bruises and hoarseness in children with asthma receiving long-term treatment with inhaled budesonide. Eur Respir J. 1998;12:130-135.
32. Dombrowski MP, Pharmacologic therapy of asthma during pregnancy. Obstet Gynecol Clin North Am. 1997;24:559-574.
33. American College of Obstetricians and Gynecologists (ACOG) and The American College of Allergy, Asthma and Immunology (ACAAI). The use of newer asthma and allergy medications during pregnancy. Ann Allergy Asthma Immunol. 2000;84:475-480.
34. Ericson A, Källén B. Use of drugs during pregnancy: unique Swedish registration method that can be improved. Inf Läkemedelsverket (Information from the Swedish Medical Products Agency). 1999;1:8-11.
35. Källén B, Rydhstroem H, Aberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol. 1999;93:392-395.
36. Norjavaara E, Gerhardsson de Verdier M. Normal pregnancy outcomes in a population-based study including 2,968 pregnant women exposed to budesonide. J Allergy Clin Immunol. 2003;111:736-742.